Cyclacel is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. The company has a strong pipeline of products at different stages of development.
Cyclacel is Nasdaq quoted (CYCC, CYCCP).Cyclacel’s corporate headquarters are in Berkeley Heights, New Jersey, with research facilities in Dundee, Scotland and Cambridge, England.